John T said...
Don't forget that the average patient was 75, so the overall survival would even out just because of the advanced age. This is probably true of most treatments given to elderly patients including primary treatments.
There was a significant difference in biochemical reoccurrance and this should be noted by younger patients that have a greater than 20 years life expectancy. But not those with negative margins, John, right?